Part of the highly regarded Specialty Imaging series, HRCT of the Lung, third edition, reflects the many recent changes in HRCT diagnostic interpretation. An easy-to-read bulleted format and thousands of state-of-the-art imaging examples guide you step by step through every aspect of thin-section CT and HRCT in the evaluation of patients with suspected lung disease. This book is an ideal resource for radiologists and internal medicine specialists who need an easily accessible tool to help them understand the indications, strengths, and limitations of HRCT in their practice.
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Dedications - p. iii 6. Contributing Authors - p. v 7. Preface - p. v 8. Acknowledgments - p. viii 9. Sections - p. xi 10. List of Tables - p. xiii 11. SECTION 1: FUNDAMENTALS OF HRCT - p. xiii 12. Chapter 1: Overview of HRCT - p. xiii 13. Chapter 2: Approach to HRCT Interpretation - p. 7 14. ANATOMY - p. 13 15. Chapter 3: Interstitial Compartments - p. 13 16. Chapter 4: Secondary Pulmonary Lobule - p. 15 17. Chapter 5: Gravitational Changes (Dependent Atelectasis) - p. 19 18. Chapter 6: Age-Related Changes - p. 21 19. Chapter 7: Normal Inspiration and Expiration - p. 25 20. TERMINOLOGY AND SIGNS - p. 29 21. Chapter 8: 3-Density Sign (Formerly Head Cheese Sign) - p. 29 22. Chapter 9: Airspace Nodules - p. 30 23. Chapter 10: Anterior Upper Lobe Sign - p. 31 24. Chapter 11: Crazy Paving - p. 32 25. Chapter 12: Cystic Lung Disease - p. 33 26. Chapter 13: Exuberant Honeycombing - p. 34 27. Chapter 14: Finger-in-Glove Sign - p. 35 28. Chapter 15: Flame-Shaped Nodules - p. 36 29. Chapter 16: Four Corners Sign - p. 37 30. Chapter 17: Ground Glass - p. 38 31. Chapter 18: Halo Sign - p. 39 32. Chapter 19: Honeycombing (Peribronchovascular) - p. 40 33. Chapter 20: Honeycombing (Subpleural) - p. 41 34. Chapter 21: Honeycombing (Unilateral) - p. 42 35. Chapter 22: Micronodules - p. 43 36. Chapter 23: Mosaic Attenuation and Air-Trapping - p. 44 37. Chapter 24: Reversed Halo Sign - p. 45 38. Chapter 25: Signet-Ring Sign - p. 46 39. Chapter 26: Straight-Edge Sign - p. 47 40. Chapter 27: Tree-in-Bud Opacities - p. 48 41. Chapter 28: Thick-Walled Cystic Lesions (Stalactite and Stalagmite Sign) - p. 49 42. DISTRIBUTION - p. 51 43. Chapter 29: Peribronchovascular - p. 51 44. Chapter 30: Centrilobular - p. 55 45. Chapter 31: Perilymphatic - p. 59 46. Chapter 32: Random - p. 63 47. Chapter 33: Peripheral - p. 64 48. SECTION 2: PATHOLOGIC PATTERNS OF INJURY - p. 65 49. Chapter 34: Approach to Pathologic Patterns of Injury - p. 65 50. Chapter 35: Diffuse Alveolar Damage - p. 71 51. Chapter 36: Diffuse Alveolar Hemorrhage With Capillaritis - p. 75 52. Chapter 37: Organizing Pneumonia - p. 79 53. Chapter 38: Constrictive Bronchiolitis - p. 83 54. SECTION 3: LARGE AIRWAYS DISEASE - p. 87 55. Chapter 39: Approach to Large Airways Disease - p. 87 56. Chapter 40: Bronchiectasis - p. 91 57. Chapter 41: Allergic Bronchopulmonary Aspergillosis - p. 95 58. Chapter 42: Williams-Campbell Syndrome - p. 99 59. Chapter 43: Mounier-Kuhn Syndrome - p. 101 60. Chapter 44: Bronchocentric Granulomatosis - p. 103 61. SECTION 4: SMALL AIRWAYS DISEASE - p. 107 62. Chapter 45: Approach to Small Airways Disease - p. 107 63. Chapter 46: Infectious Bronchiolitis - p. 111 64. Chapter 47: Asthma - p. 115 65. Chapter 48: Diffuse Aspiration Bronchiolitis - p. 117 66. Chapter 49: Respiratory Bronchiolitis - p. 121 67. Chapter 50: Follicular Bronchiolitis - p. 123 68. Chapter 51: Hypersensitivity Pneumonitis - p. 127 69. Chapter 52: Diffuse Panbronchiolitis - p. 133 70. Chapter 53: Idiopathic Constrictive Bronchiolitis - p. 137 71. Chapter 54: Swyer-James-MacLeod Syndrome - p. 141 72. Chapter 55: Bronchiolitis Obliterans Syndrome - p. 145 73. Chapter 56: Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) - p. 149 74. SECTION 5: INFECTION - p. 153 75. Chapter 57: Approach to Infection - p. 153 76. Chapter 58: Bacterial Pneumonia - p. 159 77. Chapter 59: Mycoplasma Pneumonia - p. 163 78. Chapter 60: Staphylococcus aureus Pneumonia - p. 165 79. Chapter 61: Viral Pneumonia - p. 169 80. Chapter 62: Influenza - p. 173 81. Chapter 63: COVID-19 - p. 175 82. Chapter 64: Respiratory Syncytial Virus - p. 179 83. Chapter 65: Cytomegalovirus - p. 183 84. Chapter 66: Tuberculosis - p. 187 85. Chapter 67: Nontuberculous Mycobacterial Infection - p. 193 86. Chapter 68: Endemic Fungal Infection - p. 199 87. Chapter 69: Cryptococcosis - p. 205 88. Chapter 70: Aspergillosis - p. 207 89. Chapter 71: Pneumocystis Pneumonia - p. 211 90. Chapter 72: Candidiasis - p. 215 91. SECTION 6: PNEUMOCONIOSIS - p. 217 92. Chapter 73: Approach to Pneumoconiosis - p. 217 93. Chapter 74: Silicosis and Coal Worker's Pneumoconiosis - p. 221 94. Chapter 75: Asbestosis - p. 225 95. Chapter 76: Berylliosis - p. 231 96. Chapter 77: Talcosis - p. 235 97. Chapter 78: Hard Metal Lung Disease - p. 239 98. SECTION 7: NEOPLASMS - p. 241 99. Chapter 79: Approach to Neoplasms - p. 241 100. Chapter 80: Invasive Mucinous Adenocarcinoma (Diffuse) - p. 247 101. Chapter 81: Diffuse and Multifocal Lung Cancer - p. 251 102. Chapter 82: Lymphangitic Carcinomatosis - p. 255 103. Chapter 83: Hematogenous Metastases - p. 259 104. Chapter 84: Endovascular Metastases and Tumor Emboli - p. 263 105. Chapter 85: Kaposi Sarcoma - p. 267 106. Chapter 86: Lymphangioleiomyomatosis - p. 271 107. Chapter 87: Reactive Lymphoproliferative Disorders - p. 275 108. Chapter 88: Neoplastic Lymphoproliferative Disorders - p. 281 109. Chapter 89: Pulmonary Langerhans Cell Histiocytosis - p. 287 110. Chapter 90: Erdheim-Chester Disease - p. 291 111. Chapter 91: Rosai-Dorfman Disease - p. 293 112. Chapter 92: Diffuse Pulmonary Meningotheliomatosis (DPM) - p. 295 113. SECTION 8: INTERSTITIAL PNEUMONIAS - p. 297 114. Chapter 93: Approach to Interstitial Pneumonias - p. 297 115. Chapter 94: Interstitial Lung Abnormality (ILA) - p. 303 116. Chapter 95: Idiopathic Pulmonary Fibrosis - p. 305 117. Chapter 96: Progressive Pulmonary Fibrosis (PPF) - p. 311 118. Chapter 97: Idiopathic Nonspecific Interstitial Pneumonia - p. 313 119. Chapter 98: Cryptogenic Organizing Pneumonia - p. 317 120. Chapter 99: Acute Exacerbation of Interstitial Lung Disease - p. 321 121. Chapter 100: Acute Interstitial Pneumonia - p. 325 122. Chapter 101: Idiopathic Lymphoid Interstitial Pneumonia - p. 329 123. Chapter 102: Pleuroparenchymal Fibroelastosis - p. 333 124. Chapter 103: Airway-Centered Interstitial Fibrosis - p. 339 125. Chapter 104: Interstitial Pneumonia With Autoimmune Features (IPAF) - p. 343 126. Chapter 105: Approach to Smoking-Related Interstitial Lung Diseases - p. 349 127. Chapter 106: Respiratory Bronchiolitis-Interstitial Lung Disease - p. 353 128. Chapter 107: Desquamative Interstitial Pneumonia - p. 355 129. Chapter 108: Syndrome of Combined Pulmonary Fibrosis and Emphysema - p. 359 130. Chapter 109: Smoking-Related Interstitial Fibrosis (SRIF) - p. 365 131. Chapter 110: Airspace Enlargement With Fibrosis (AEF) - p. 367 132. SECTION 9: AUTOIMMUNE DISEASES - p. 369 133. Chapter 111: Approach to Connective Tissue Disease-Associated Interstitial Lung Disease - p. 369 134. Chapter 112: Rheumatoid Arthritis - p. 375 135. Chapter 113: Progressive Systemic Sclerosis - p. 379 136. Chapter 114: Idiopathic Inflammatory Myopathies - p. 383 137. Chapter 115: Sjögren Syndrome - p. 387 138. Chapter 116: Mixed Connective Tissue Disease - p. 393 139. Chapter 117: Systemic Lupus Erythematosus - p. 395 140. Chapter 118: Granulomatosis With Polyangiitis (GPA) - p. 401 141. Chapter 119: Eosinophilic Granulomatosis With Polyangiitis - p. 407 142. Chapter 120: Microscopic Polyangiitis - p. 411 143. Chapter 121: Ankylosing Spondylitis - p. 415 144. Chapter 122: Inflammatory Bowel Disease-Associated Lung Disease - p. 419 145. SECTION 10: VASCULAR DISEASE - p. 423 146. Chapter 123: Approach to Vascular Disease - p. 423 147. Chapter 124: Pulmonary Edema - p. 427 148. Chapter 125: Hepatopulmonary Syndrome - p. 433 149. Chapter 126: Pulmonary Hypertension - p. 435 150. Chapter 127: Pulmonary Venoocclusive Disease/Pulmonary Capillary Hemangiomatosis - p. 439 151. Chapter 128: Excipient Lung Disease (Talc/Cellulose Granulomatosis) - p. 441 152. Chapter 129: Chronic Thromboembolic Pulmonary Hypertension - p. 447 153. SECTION 11: INHALATIONAL, INFLAMMATORY, METABOLIC, AND POST TREATMENT - p. 451 154. Chapter 130: Approach to Inhalational, Inflammatory, Metabolic, and Post Treatment - p. 451 155. ASPIRATION/INHALATION - p. 459 156. Chapter 131: Spectrum of Aspiration-Related Disorders - p. 459 157. Chapter 132: Lipoid Pneumonia - p. 463 158. Chapter 133: Inhalational Lung Injury - p. 467 159. Chapter 134: E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) - p. 471 160. Chapter 135: Recurrent Gastric Acid Aspiration and Dendriform Pulmonary Ossification - p. 473 161. INFLAMMATORY - p. 475 162. Chapter 136: Sarcoidosis - p. 475 163. Chapter 137: Acute Eosinophilic Pneumonia - p. 481 164. Chapter 138: Chronic Eosinophilic Pneumonia - p. 483 165. Chapter 139: Other Eosinophilic Disorders - p. 487 166. METABOLIC OR DEGENERATIVE - p. 489 167. Chapter 140: Amyloidosis - p. 489 168. Chapter 141: Light Chain Deposition Disease - p. 493 169. Chapter 142: Pulmonary Alveolar Proteinosis - p. 495 170. Chapter 143: Metastatic Pulmonary Calcification - p. 501 171. Chapter 144: Diffuse Pulmonary Ossification - p. 505 172. Chapter 145: Emphysema - p. 507 173. Chapter 146: Idiopathic Pulmonary Hemosiderosis - p. 511 174. POST TREATMENT - p. 513 175. Chapter 147: Radiation-Induced Lung Disease - p. 513 176. Chapter 148: Drug-Induced Lung Disease - p. 519 177. Chapter 149: Immune Checkpoint Inhibitor-Related Pneumonitis - p. 523 178. SECTION 12: CONGENITAL - p. 527 179. Chapter 150: Approach to Congenital - p. 527 180. Chapter 151: Familial Idiopathic Pulmonary Fibrosis - p. 535 181. Chapter 152: Birt-Hogg-Dubé Syndrome - p. 537 182. Chapter 153: Hermansky-Pudlak Syndrome - p. 541 183. Chapter 154: Tuberous Sclerosis Complex - p. 543 184. Chapter 155: Neurofibromatosis - p. 547 185. Chapter 156: Alveolar Microlithiasis - p. 549 186. Chapter 157: α-1 Antitrypsin Deficiency - p. 551 187. Chapter 158: Primary Ciliary Dyskinesia - p. 553 188. Chapter 159: Chronic Granulomatous Disease - p. 557 189. Chapter 160: Common Variable Immunodeficiency - p. 559 190. Chapter 161: Primary Immunodeficiency Disorders - p. 561 191. Chapter 162: Cystic Fibrosis - p. 565 192. Chapter 163: Childhood Interstitial Lung Disease (chILD) - p. 569 193. Chapter 164: Diffuse Pulmonary Lymphangiomatosis - p. 571 194. Chapter 165: Proximal Interruption of Pulmonary Artery - p. 573 195. INDEX - p. 577
Part of the highly regarded Specialty Imaging series, HRCT of the Lung, third edition, reflects the many recent changes in HRCT diagnostic interpretation. An easy-to-read bulleted format and thousands of state-of-the-art imaging examples guide you step by step through every aspect of thin-section CT and HRCT in the evaluation of patients with suspected lung disease. This book is an ideal resource for radiologists and internal medicine specialists who need an easily accessible tool to help them understand the indications, strengths, and limitations of HRCT in their practice.
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Dedications - p. iii 6. Contributing Authors - p. v 7. Preface - p. v 8. Acknowledgments - p. viii 9. Sections - p. xi 10. List of Tables - p. xiii 11. SECTION 1: FUNDAMENTALS OF HRCT - p. xiii 12. Chapter 1: Overview of HRCT - p. xiii 13. Chapter 2: Approach to HRCT Interpretation - p. 7 14. ANATOMY - p. 13 15. Chapter 3: Interstitial Compartments - p. 13 16. Chapter 4: Secondary Pulmonary Lobule - p. 15 17. Chapter 5: Gravitational Changes (Dependent Atelectasis) - p. 19 18. Chapter 6: Age-Related Changes - p. 21 19. Chapter 7: Normal Inspiration and Expiration - p. 25 20. TERMINOLOGY AND SIGNS - p. 29 21. Chapter 8: 3-Density Sign (Formerly Head Cheese Sign) - p. 29 22. Chapter 9: Airspace Nodules - p. 30 23. Chapter 10: Anterior Upper Lobe Sign - p. 31 24. Chapter 11: Crazy Paving - p. 32 25. Chapter 12: Cystic Lung Disease - p. 33 26. Chapter 13: Exuberant Honeycombing - p. 34 27. Chapter 14: Finger-in-Glove Sign - p. 35 28. Chapter 15: Flame-Shaped Nodules - p. 36 29. Chapter 16: Four Corners Sign - p. 37 30. Chapter 17: Ground Glass - p. 38 31. Chapter 18: Halo Sign - p. 39 32. Chapter 19: Honeycombing (Peribronchovascular) - p. 40 33. Chapter 20: Honeycombing (Subpleural) - p. 41 34. Chapter 21: Honeycombing (Unilateral) - p. 42 35. Chapter 22: Micronodules - p. 43 36. Chapter 23: Mosaic Attenuation and Air-Trapping - p. 44 37. Chapter 24: Reversed Halo Sign - p. 45 38. Chapter 25: Signet-Ring Sign - p. 46 39. Chapter 26: Straight-Edge Sign - p. 47 40. Chapter 27: Tree-in-Bud Opacities - p. 48 41. Chapter 28: Thick-Walled Cystic Lesions (Stalactite and Stalagmite Sign) - p. 49 42. DISTRIBUTION - p. 51 43. Chapter 29: Peribronchovascular - p. 51 44. Chapter 30: Centrilobular - p. 55 45. Chapter 31: Perilymphatic - p. 59 46. Chapter 32: Random - p. 63 47. Chapter 33: Peripheral - p. 64 48. SECTION 2: PATHOLOGIC PATTERNS OF INJURY - p. 65 49. Chapter 34: Approach to Pathologic Patterns of Injury - p. 65 50. Chapter 35: Diffuse Alveolar Damage - p. 71 51. Chapter 36: Diffuse Alveolar Hemorrhage With Capillaritis - p. 75 52. Chapter 37: Organizing Pneumonia - p. 79 53. Chapter 38: Constrictive Bronchiolitis - p. 83 54. SECTION 3: LARGE AIRWAYS DISEASE - p. 87 55. Chapter 39: Approach to Large Airways Disease - p. 87 56. Chapter 40: Bronchiectasis - p. 91 57. Chapter 41: Allergic Bronchopulmonary Aspergillosis - p. 95 58. Chapter 42: Williams-Campbell Syndrome - p. 99 59. Chapter 43: Mounier-Kuhn Syndrome - p. 101 60. Chapter 44: Bronchocentric Granulomatosis - p. 103 61. SECTION 4: SMALL AIRWAYS DISEASE - p. 107 62. Chapter 45: Approach to Small Airways Disease - p. 107 63. Chapter 46: Infectious Bronchiolitis - p. 111 64. Chapter 47: Asthma - p. 115 65. Chapter 48: Diffuse Aspiration Bronchiolitis - p. 117 66. Chapter 49: Respiratory Bronchiolitis - p. 121 67. Chapter 50: Follicular Bronchiolitis - p. 123 68. Chapter 51: Hypersensitivity Pneumonitis - p. 127 69. Chapter 52: Diffuse Panbronchiolitis - p. 133 70. Chapter 53: Idiopathic Constrictive Bronchiolitis - p. 137 71. Chapter 54: Swyer-James-MacLeod Syndrome - p. 141 72. Chapter 55: Bronchiolitis Obliterans Syndrome - p. 145 73. Chapter 56: Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) - p. 149 74. SECTION 5: INFECTION - p. 153 75. Chapter 57: Approach to Infection - p. 153 76. Chapter 58: Bacterial Pneumonia - p. 159 77. Chapter 59: Mycoplasma Pneumonia - p. 163 78. Chapter 60: Staphylococcus aureus Pneumonia - p. 165 79. Chapter 61: Viral Pneumonia - p. 169 80. Chapter 62: Influenza - p. 173 81. Chapter 63: COVID-19 - p. 175 82. Chapter 64: Respiratory Syncytial Virus - p. 179 83. Chapter 65: Cytomegalovirus - p. 183 84. Chapter 66: Tuberculosis - p. 187 85. Chapter 67: Nontuberculous Mycobacterial Infection - p. 193 86. Chapter 68: Endemic Fungal Infection - p. 199 87. Chapter 69: Cryptococcosis - p. 205 88. Chapter 70: Aspergillosis - p. 207 89. Chapter 71: Pneumocystis Pneumonia - p. 211 90. Chapter 72: Candidiasis - p. 215 91. SECTION 6: PNEUMOCONIOSIS - p. 217 92. Chapter 73: Approach to Pneumoconiosis - p. 217 93. Chapter 74: Silicosis and Coal Worker's Pneumoconiosis - p. 221 94. Chapter 75: Asbestosis - p. 225 95. Chapter 76: Berylliosis - p. 231 96. Chapter 77: Talcosis - p. 235 97. Chapter 78: Hard Metal Lung Disease - p. 239 98. SECTION 7: NEOPLASMS - p. 241 99. Chapter 79: Approach to Neoplasms - p. 241 100. Chapter 80: Invasive Mucinous Adenocarcinoma (Diffuse) - p. 247 101. Chapter 81: Diffuse and Multifocal Lung Cancer - p. 251 102. Chapter 82: Lymphangitic Carcinomatosis - p. 255 103. Chapter 83: Hematogenous Metastases - p. 259 104. Chapter 84: Endovascular Metastases and Tumor Emboli - p. 263 105. Chapter 85: Kaposi Sarcoma - p. 267 106. Chapter 86: Lymphangioleiomyomatosis - p. 271 107. Chapter 87: Reactive Lymphoproliferative Disorders - p. 275 108. Chapter 88: Neoplastic Lymphoproliferative Disorders - p. 281 109. Chapter 89: Pulmonary Langerhans Cell Histiocytosis - p. 287 110. Chapter 90: Erdheim-Chester Disease - p. 291 111. Chapter 91: Rosai-Dorfman Disease - p. 293 112. Chapter 92: Diffuse Pulmonary Meningotheliomatosis (DPM) - p. 295 113. SECTION 8: INTERSTITIAL PNEUMONIAS - p. 297 114. Chapter 93: Approach to Interstitial Pneumonias - p. 297 115. Chapter 94: Interstitial Lung Abnormality (ILA) - p. 303 116. Chapter 95: Idiopathic Pulmonary Fibrosis - p. 305 117. Chapter 96: Progressive Pulmonary Fibrosis (PPF) - p. 311 118. Chapter 97: Idiopathic Nonspecific Interstitial Pneumonia - p. 313 119. Chapter 98: Cryptogenic Organizing Pneumonia - p. 317 120. Chapter 99: Acute Exacerbation of Interstitial Lung Disease - p. 321 121. Chapter 100: Acute Interstitial Pneumonia - p. 325 122. Chapter 101: Idiopathic Lymphoid Interstitial Pneumonia - p. 329 123. Chapter 102: Pleuroparenchymal Fibroelastosis - p. 333 124. Chapter 103: Airway-Centered Interstitial Fibrosis - p. 339 125. Chapter 104: Interstitial Pneumonia With Autoimmune Features (IPAF) - p. 343 126. Chapter 105: Approach to Smoking-Related Interstitial Lung Diseases - p. 349 127. Chapter 106: Respiratory Bronchiolitis-Interstitial Lung Disease - p. 353 128. Chapter 107: Desquamative Interstitial Pneumonia - p. 355 129. Chapter 108: Syndrome of Combined Pulmonary Fibrosis and Emphysema - p. 359 130. Chapter 109: Smoking-Related Interstitial Fibrosis (SRIF) - p. 365 131. Chapter 110: Airspace Enlargement With Fibrosis (AEF) - p. 367 132. SECTION 9: AUTOIMMUNE DISEASES - p. 369 133. Chapter 111: Approach to Connective Tissue Disease-Associated Interstitial Lung Disease - p. 369 134. Chapter 112: Rheumatoid Arthritis - p. 375 135. Chapter 113: Progressive Systemic Sclerosis - p. 379 136. Chapter 114: Idiopathic Inflammatory Myopathies - p. 383 137. Chapter 115: Sjögren Syndrome - p. 387 138. Chapter 116: Mixed Connective Tissue Disease - p. 393 139. Chapter 117: Systemic Lupus Erythematosus - p. 395 140. Chapter 118: Granulomatosis With Polyangiitis (GPA) - p. 401 141. Chapter 119: Eosinophilic Granulomatosis With Polyangiitis - p. 407 142. Chapter 120: Microscopic Polyangiitis - p. 411 143. Chapter 121: Ankylosing Spondylitis - p. 415 144. Chapter 122: Inflammatory Bowel Disease-Associated Lung Disease - p. 419 145. SECTION 10: VASCULAR DISEASE - p. 423 146. Chapter 123: Approach to Vascular Disease - p. 423 147. Chapter 124: Pulmonary Edema - p. 427 148. Chapter 125: Hepatopulmonary Syndrome - p. 433 149. Chapter 126: Pulmonary Hypertension - p. 435 150. Chapter 127: Pulmonary Venoocclusive Disease/Pulmonary Capillary Hemangiomatosis - p. 439 151. Chapter 128: Excipient Lung Disease (Talc/Cellulose Granulomatosis) - p. 441 152. Chapter 129: Chronic Thromboembolic Pulmonary Hypertension - p. 447 153. SECTION 11: INHALATIONAL, INFLAMMATORY, METABOLIC, AND POST TREATMENT - p. 451 154. Chapter 130: Approach to Inhalational, Inflammatory, Metabolic, and Post Treatment - p. 451 155. ASPIRATION/INHALATION - p. 459 156. Chapter 131: Spectrum of Aspiration-Related Disorders - p. 459 157. Chapter 132: Lipoid Pneumonia - p. 463 158. Chapter 133: Inhalational Lung Injury - p. 467 159. Chapter 134: E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) - p. 471 160. Chapter 135: Recurrent Gastric Acid Aspiration and Dendriform Pulmonary Ossification - p. 473 161. INFLAMMATORY - p. 475 162. Chapter 136: Sarcoidosis - p. 475 163. Chapter 137: Acute Eosinophilic Pneumonia - p. 481 164. Chapter 138: Chronic Eosinophilic Pneumonia - p. 483 165. Chapter 139: Other Eosinophilic Disorders - p. 487 166. METABOLIC OR DEGENERATIVE - p. 489 167. Chapter 140: Amyloidosis - p. 489 168. Chapter 141: Light Chain Deposition Disease - p. 493 169. Chapter 142: Pulmonary Alveolar Proteinosis - p. 495 170. Chapter 143: Metastatic Pulmonary Calcification - p. 501 171. Chapter 144: Diffuse Pulmonary Ossification - p. 505 172. Chapter 145: Emphysema - p. 507 173. Chapter 146: Idiopathic Pulmonary Hemosiderosis - p. 511 174. POST TREATMENT - p. 513 175. Chapter 147: Radiation-Induced Lung Disease - p. 513 176. Chapter 148: Drug-Induced Lung Disease - p. 519 177. Chapter 149: Immune Checkpoint Inhibitor-Related Pneumonitis - p. 523 178. SECTION 12: CONGENITAL - p. 527 179. Chapter 150: Approach to Congenital - p. 527 180. Chapter 151: Familial Idiopathic Pulmonary Fibrosis - p. 535 181. Chapter 152: Birt-Hogg-Dubé Syndrome - p. 537 182. Chapter 153: Hermansky-Pudlak Syndrome - p. 541 183. Chapter 154: Tuberous Sclerosis Complex - p. 543 184. Chapter 155: Neurofibromatosis - p. 547 185. Chapter 156: Alveolar Microlithiasis - p. 549 186. Chapter 157: α-1 Antitrypsin Deficiency - p. 551 187. Chapter 158: Primary Ciliary Dyskinesia - p. 553 188. Chapter 159: Chronic Granulomatous Disease - p. 557 189. Chapter 160: Common Variable Immunodeficiency - p. 559 190. Chapter 161: Primary Immunodeficiency Disorders - p. 561 191. Chapter 162: Cystic Fibrosis - p. 565 192. Chapter 163: Childhood Interstitial Lung Disease (chILD) - p. 569 193. Chapter 164: Diffuse Pulmonary Lymphangiomatosis - p. 571 194. Chapter 165: Proximal Interruption of Pulmonary Artery - p. 573 195. INDEX - p. 577
